Ipsen (Spain)

Recent papers from Ipsen (Spain)

1. Delphi Consensus on the Management of Spanish Patients with Post-Stroke Hemiplegic Shoulder Pain Treated with Botulinum Toxin A: Result StudyToxins · 2025
2. Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine LearningToxins · 2024
3. Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN StudyDrugs in Context · 2024
4. Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register studyJournal of Thrombosis and Thrombolysis · 2024
5. Standards of Care for Medical Management of Acromegaly in Pituitary Tumor Centers of Excellence (PTCOE)2024
6. Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature reviewCancer Treatment Reviews · 2023
7. Systematic review and cost-effectiveness analysis of the treatment of post-stroke spasticity with abobotulinumtoxinA compared to physiotherapyFarmacia Hospitalaria · 2023
8. Collaborative permeation of drug and excipients in transdermal formulations. In vitro scrutiny for ethanol:limonene combinationsEuropean Journal of Pharmaceutics and Biopharmaceutics · 2022
9. Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE studyWorld Journal of Urology · 2022
10. Liver-Directed and Systemic Therapy Options for Hepatocellular CarcinomaJournal of the National Comprehensive Cancer Network · 2022
11. Cabozantinib combination therapy for the treatment of solid tumors: a systematic reviewTherapeutic Advances in Medical Oncology · 2022
12. Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY studyClinical & Translational Oncology · 2021
13. Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect ComparisonAdvances in Therapy · 2021
14. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)Health and Quality of Life Outcomes · 2021
15. Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic CancerJournal of Clinical Oncology · 2019
16. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialJournal of Clinical Oncology · 2017
17. Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II studyBMC Cancer · 2013
18. Experimental Observation of Double-Walled Peptide Nanotubes and Monodispersity Modeling of the Number of WallsLangmuir · 2013
19. Lamination and spherulite-like compaction of a hormone’s native amyloid-like nanofibrils: spectroscopic insights into key interactionsFaraday Discussions · 2013
20. Immunoresistance in Cervical Dystonia Patients After Treatment With AbobotulinumtoxinAInternational Journal of Neuroscience · 2012